These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27814841)

  • 1. Industry Funding of Cancer Patient Advocacy Organizations.
    Abola MV; Prasad V
    Mayo Clin Proc; 2016 Nov; 91(11):1668-1670. PubMed ID: 27814841
    [No Abstract]   [Full Text] [Related]  

  • 2. Financial stability in biobanking: unique challenges for disease-focused foundations and patient advocacy organizations.
    Bromley RL
    Biopreserv Biobank; 2014 Oct; 12(5):294-9. PubMed ID: 25313427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs.
    Mulinari S; Vilhelmsson A; Rickard E; Ozieranski P
    PLoS One; 2020; 15(6):e0235021. PubMed ID: 32579571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More than 80% of US patients' groups take industry funds, study finds.
    McCarthy M
    BMJ; 2017 Mar; 356():j1180. PubMed ID: 28264805
    [No Abstract]   [Full Text] [Related]  

  • 5. Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark.
    Mulinari S; Pashley D; Ozieranski P
    Health Policy; 2022 Dec; 126(12):1256-1262. PubMed ID: 36371347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO's web-based public hearings: hijacked by pharma?
    Wibulpolprasert S; Moosa S; Satyanarayana K; Samarage S; Tangcharoensathien V
    Lancet; 2007 Nov; 370(9601):1754. PubMed ID: 18022221
    [No Abstract]   [Full Text] [Related]  

  • 7. Attorneys as advocates: organizations step up to help patients navigate the legal and financial issues that often accompany a cancer diagnosis.
    Printz C
    Cancer; 2015 Jan; 121(1):1-2. PubMed ID: 25522258
    [No Abstract]   [Full Text] [Related]  

  • 8. The increasingly complex world of cancer patient advocacy organizations.
    Markman M
    Curr Oncol Rep; 2008 Jan; 10(1):1-2. PubMed ID: 18366953
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug companies and patient groups: the influence of funding.
    Prescrire Int; 2011 Dec; 20(122):306. PubMed ID: 22216553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activists dialog about pricing.
    AIDS Patient Care STDS; 1999 Apr; 13(4):247. PubMed ID: 10351896
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical Representation by Patient Advocacy Organizations Also Requires Responsible Management of Potential Financial Conflicts of Interest.
    Bruno B; Rose S
    Am J Bioeth; 2020 May; 20(4):59-61. PubMed ID: 32223632
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationships between patient associations and companies: ethical aspects].
    Roche G
    Presse Med; 2012 May; 41 Suppl 1():S45-7. PubMed ID: 22459992
    [No Abstract]   [Full Text] [Related]  

  • 13. Are psychiatrists betraying their patients?
    Mosher LR; Goodwin FK; Thompson J; Hyman SE; Emmet W
    Psychol Today; 1999; 32(5):40-42, 80, 82. PubMed ID: 11660751
    [No Abstract]   [Full Text] [Related]  

  • 14. Health advocacy and the funding of mental health services reform.
    Allison S; Nance M; Bastiampillai T; Hooper J; Roeger L; Goldney R
    Aust N Z J Psychiatry; 2014 Sep; 48(9):802-4. PubMed ID: 25147290
    [No Abstract]   [Full Text] [Related]  

  • 15. Lifting the veil of secrecy from industry funding of nonprofit health organizations.
    Jacobson MF
    Int J Occup Environ Health; 2005; 11(4):349-55. PubMed ID: 16350468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More clarity needed in funding of patient groups.
    Prescrire Int; 2010 Feb; 19(105):43. PubMed ID: 20455346
    [No Abstract]   [Full Text] [Related]  

  • 17. How disease advocacy organizations participate in clinical research: a survey of genetic organizations.
    Landy DC; Brinich MA; Colten ME; Horn EJ; Terry SF; Sharp RR
    Genet Med; 2012 Feb; 14(2):223-8. PubMed ID: 22261756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial counseling service (outstationed eligibility).
    Wegner BA
    NAHAM Manage J; 1993; 18(3):18-9. PubMed ID: 10123911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dilemma of aged-care funding.
    Belton R
    Nurs N Z; 2006 Aug; 12(7):4. PubMed ID: 17076289
    [No Abstract]   [Full Text] [Related]  

  • 20. [Workshops A1 to A5].
    Med Sci (Paris); 2014 Apr; 30 Spe(1):33-9. PubMed ID: 24755177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.